A charity is carrying out clinical trials on a new cancer treatment.
Cancer Research UK is engaged in tests on temozolomide and olaparib to find out how a combination of them could help to treat brain cancer.
Dr Nigel Blackburn, the charity's director of drug development, commented: "It's incredibly encouraging to launch this trial combining two drugs which have both been developed through work led by Cancer Research UK scientists."
He said the group hopes the new type of cancer treatment will be effective in lengthening the life expectancies of patients.
Dr Blackburn added that Cancer Research UK is investing "heavily" in coming up with new targeted treatments aimed at tackling various forms of the disease.
He stated that it is awaiting results of these various clinical trials "with great interest".
According to data from Cancer Research UK, malignant brain tumours and growths in the central nervous system were responsible for more than 3,600 fatalities in Britain during 2008.
© Adfero Ltd
Cancer treatment news : 13 September 2011